XEXYMIX Corporation (KOSDAQ:337930)

Elevation Oncology Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	178,050	181,438	185,843	139,602	284,877	202,036
Market Cap Growth	22.06%	-2.37%	33.12%	-51.00%	41.00%	-
Enterprise Value	151,502	167,317	173,473	125,630	270,176	179,995
Last Close Price	6020.00	5919.13	5970.55	4452.40	8888.64	6471.83
PE Ratio	10.09	8.78	16.54	13.88	36.90	28.89
Forward PE	7.23	5.89	7.30	5.20	14.65	9.81
PS Ratio	0.66	0.67	0.80	0.68	1.72	1.46
PB Ratio	1.62	1.59	2.00	1.72	3.80	3.21
P/TBV Ratio	1.70	1.67	2.18	1.88	5.22	3.36
P/FCF Ratio	4.55	6.52	16.18	27.95	26.06	-
P/OCF Ratio	4.35	6.10	14.12	20.39	21.82	-
EV/Sales Ratio	0.56	0.62	0.75	0.61	1.63	1.30
EV/EBITDA Ratio	4.75	4.91	6.69	4.81	14.41	16.04
EV/EBIT Ratio	6.79	6.72	9.59	6.58	19.56	22.38
EV/FCF Ratio	3.87	6.02	15.10	25.16	24.71	-
Debt / Equity Ratio	0.25	0.25	0.10	0.08	0.17	0.07
Debt / EBITDA Ratio	0.84	0.83	0.36	0.23	0.69	0.41
Debt / FCF Ratio	0.69	1.02	0.82	1.22	1.19	-
Asset Turnover	1.57	1.78	1.88	1.84	1.76	2.31
Inventory Turnover	1.41	1.70	1.61	1.89	1.97	2.49
Quick Ratio	1.08	2.13	0.83	0.73	1.07	1.98
Current Ratio	2.29	4.11	2.77	2.61	2.48	4.96
Return on Equity (ROE)	18.32%	20.18%	14.63%	18.28%	18.54%	17.89%
Return on Assets (ROA)	8.11%	10.18%	9.14%	10.62%	9.13%	8.39%
Return on Capital (ROIC)	10.61%	12.70%	11.92%	13.61%	11.10%	10.11%
Return on Capital Employed (ROCE)	19.20%	18.00%	18.40%	22.90%	16.60%	12.20%
Earnings Yield	10.54%	11.39%	6.04%	7.21%	2.71%	3.46%
FCF Yield	22.00%	15.33%	6.18%	3.58%	3.84%	-8.44%
Dividend Yield	3.99%	3.04%	-	-	-	-
Payout Ratio	15.61%	14.18%	20.84%	34.91%	49.63%	-
Buyback Yield / Dilution	-9.76%	-10.78%	0.05%	-1.27%	-14.43%	-18.65%
Total Shareholder Return	-5.82%	-7.74%	0.05%	-1.27%	-14.43%	-18.65%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.